Shire moves within MA; Bosch Packaging expands in China;

> Shire expects to complete construction of its newest building next month and begin moving 250 employees from Cambridge to Lexington, MA. Story

> Process provider Bosch Packaging Technology is expanding operations in China and enlarging its site in Hangzhou, Zhejiang province, adding 1,400 square meters for 120 workers. Story

> The FDA has walloped API-maker Yag-Mag Labs of India with a warning letter and an import alert. Warning Letter 320-11-20

> Stem-cell treatment developer Mesoblast says it will form a manufacturing alliance with Lonza Group as it prepares to mass-produce its regenerative therapies. Release

> Nigerian medicine distributor Greenlife Pharmaceutical and Indian drugmaker Bliss GVS will use Sproxil's anti-counterfeiting platform MAS (for medicine authentication system) with the antimalarial drug Lonart-DS. Article

> GlaxoSmithKline ($GSK) will collaborate with Formula 1 racing developer McLaren Group, focusing initially on innovation in manufacturing and R&D. Story

> Dozens of firefighters and some employees of Orchid Chemical and Pharmaceuticals fought a fire for 5 hours in Sholinganallur, south of Chennai, containing damage to computers, lab equipment and furniture; the fire was caused by heating equipment left on overnight. Item

> GSK ($GSK) has opened the Department of Soft Gelatinous Capsules in Poznan, Poland. More

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.